Arrowhead Pharmaceuticals (NASDAQ:ARWR) said the FDA has accepted its New Drug Application for its drug plozasiran for the ...
Two Canadian mothers were pressured by a luxury resort in Cancun, Mexico, to sign NDA agreements in order to get medical help ...
Johnson & Johnson announced it has initiated the submission of an original New Drug Application with the U.S. FDA for TAR-200 for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback